April 2014 FDA Recall Drug by Caraco Pharmaceutical Laboratories, Ltd.
D-1407-2014 - Lack of Assurance of Sterility
This Class II drug recall was voluntarily initiated by Caraco Pharmaceutical Laboratories, Ltd. on April 9, 2014 for the product Drug. The FDA reported the reason for recall as lack of assurance of sterility. The product was distributed in OH and the recall is currently terminated.
Recall Number: D-1407-2014
Lack of Assurance of Sterility: A particle excursion for a different batch of the same product may lead to a lack of sterility assurance.
04-09-2014
07-02-2014
200 vials
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Caraco Pharmaceutical Laboratories, Ltd.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
OH
09-29-2014
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Gemcitabine For Injection USP, 1 g, (lyophilized), For Intravenous Use Only, Sterile Single Use Vial, Rx only, Manufactured by: Sun Pharmaceutical Ind. Ltd, Gujarat, India, NDC 47335-154-40
Batch or Lot Expiration Information
Lot# JKM7188A